Cargando…
Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model
Tissue-type plasminogen activator (t-PA) remains the only approved therapy for acute ischemic stroke but has a restrictive treatment time window of 4.5 hr. Prolonged ischemia causes blood-brain barrier (BBB) damage and increases the incidence of hemorrhagic transformation (HT) secondary to reperfusi...
Autores principales: | Ma, YinZhong, Li, Li, Kong, LingLei, Zhu, ZhiMei, Zhang, Wen, Song, JunKe, Chang, Junlei, Du, GuanHua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937499/ https://www.ncbi.nlm.nih.gov/pubmed/29850586 http://dx.doi.org/10.1155/2018/8943210 |
Ejemplares similares
-
Pinocembrin alleviates memory impairment in transient global cerebral ischemic rats
por: MENG, FANRUI, et al.
Publicado: (2014) -
Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke
por: dela Peña, Ike C., et al.
Publicado: (2018) -
Pinocembrin Protects the Brain against Ischemia-Reperfusion Injury and Reverses the Autophagy Dysfunction in the Penumbra Area
por: Zhao, Gang, et al.
Publicado: (2014) -
Optimization of
Pinocembrin Biosynthesis in Saccharomyces cerevisiae
por: Tous Mohedano, Marta, et al.
Publicado: (2022) -
The Anti-Campylobacter Activity and Mechanisms of Pinocembrin Action
por: Klančnik, Anja, et al.
Publicado: (2019)